Lv1
20 积分 2023-02-07 加入
NCCN Guidelines® Insights: Hepatocellular Carcinoma, Version 2.2026
7小时前
求助中
Systemic antitumor responses to hypofractionated radiotherapy plus Poly(I:C) in advanced hepatocellular carcinoma: A phase 2 trial
1天前
已完结
Gemcitabine-cisplatin plus durvalumab in advanced intrahepatic cholangiocarcinoma: effectiveness outcomes and characterization of the tumor microenvironment
6个月前
已完结
皖公网安备34019202002308
